More tools:Markets·Screener·Research·Chat

BIO-key International, Inc. Common Stock (BKYI) Financial Statements

BIO-key International, Inc. Common Stock
SIC 7372 · SERVICES-PREPACKAGED SOFTWARE
FIGI BBG001S7ZTY2
XNAS · usd
2.74▲ 0.07 (2.62%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close2.67
Day's Range2.57 – 2.77
52-Week Range0.46 – 5.76
Volume12.6K
Avg Volume59.0K
Share Statistics
Shares Outstanding
Employees52
ExchangeXNAS
Listed1997-02-24
Share count as of August 11, 2026
Loading Income Statement…
Key questions about BIO-key International, Inc. Common Stock (BKYI)
What is BIO-key International, Inc. Common Stock's Market Cap?
BIO-key International, Inc. Common Stock's Market Cap is $3.9M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Price / Sales?
BIO-key International, Inc. Common Stock's Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Revenue (TTM)?
BIO-key International, Inc. Common Stock's Revenue (TTM) is $6.7M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Net Income (TTM)?
BIO-key International, Inc. Common Stock's Net Income (TTM) is -$6.0M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's EBITDA?
BIO-key International, Inc. Common Stock's EBITDA is -$5.7M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Diluted EPS (TTM)?
BIO-key International, Inc. Common Stock's Diluted EPS (TTM) is -4.20, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's EBITDA Margin?
BIO-key International, Inc. Common Stock's EBITDA Margin is -85.2%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Revenues
YoY growth+13.1%+33.5%-25.9%-27.7%
Costs and other expenses
Cost of Goods and Services Sold
Gross profit
% of revenue87.2%82.5%75.0%76.9%
Operating expenses
Selling, general and administrative
Research, development and engineering
Total operating expenses
% of revenue114.8%89.8%463.5%134.5%
Operating loss
% of revenue-27.6%-7.4%-388.5%-57.6%
Other income (expense)
Interest income
Loan fee amortization
Interest expense
Total other income (expense), net
Loss before provision for income tax
Provision for income taxes
Net loss
% of revenue-30.0%-9.6%-395.8%-62.3%
Net loss
% of revenue-30.0%-9.6%-395.8%-62.3%
Basic and diluted loss per common share (in dollars per share)—